* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Thursday, August 28, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    ‘SNL’ Parts Ways With Emil Wakim Amid Rumored Season 51 Cast Shakeup – yahoo.com

    SNL Shakes Up Season 51 Cast with Emil Wakim’s Surprising Exit

    Do you have a favorable or an unfavorable opinion of Taylor Swift? – YouGov

    Do You Love Taylor Swift or Not? Share Your Thoughts!

    Upload Season 4 Review – yahoo.com

    Upload Season 4 Review: A Thrilling New Chapter Unveiled

    ‘The Roses’ review: Olivia Colman, Benedict Cumberbatch sparkle in dark comedy – Yakima Herald-Republic

    The Roses’ Review: Olivia Colman and Benedict Cumberbatch Shine in Dark Comedy Delight

    ‘When Calls the Heart’ Fans All Want the Same Thing After Seeing the Show’s Latest Update – yahoo.com

    When Calls the Heart’ Fans Rally Together in Excitement Over Exciting New Update!

    Quotes of the Week: Peacemaker, Project Runway, Countdown and More – yahoo.com

    This Week’s Most Memorable Quotes from Peacemaker, Project Runway, Countdown, and More!

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    ITSWC 2025: Thursday sessions guide – Traffic Technology Today

    Your Ultimate Guide to Thursday Sessions at ITSWC 2025

    MC Machinery Technology Summit Showcases Manufacturing Innovations – Modern Machine Shop

    MC Machinery Technology Summit Unveils Cutting-Edge Manufacturing Innovations

    US-ROK Technology Cooperation Faces Rising Tensions – The National Interest

    Rising Tensions Put US-South Korea Technology Partnership to the Test

    The Role of AI and Technology in Shaping the Future of Interactive Entertainment – Technology Org

    How AI and Technology Are Transforming the Future of Interactive Entertainment

    Ten upcoming sports stadiums where technology takes to the field – Dezeen

    10 Futuristic Sports Stadiums Revolutionizing the Game with Cutting-Edge Technology

    Figure Technology Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering – Business Wire

    Figure Technology Solutions, Inc. Unveils Exciting Plans for Its Upcoming Initial Public Offering

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    ‘SNL’ Parts Ways With Emil Wakim Amid Rumored Season 51 Cast Shakeup – yahoo.com

    SNL Shakes Up Season 51 Cast with Emil Wakim’s Surprising Exit

    Do you have a favorable or an unfavorable opinion of Taylor Swift? – YouGov

    Do You Love Taylor Swift or Not? Share Your Thoughts!

    Upload Season 4 Review – yahoo.com

    Upload Season 4 Review: A Thrilling New Chapter Unveiled

    ‘The Roses’ review: Olivia Colman, Benedict Cumberbatch sparkle in dark comedy – Yakima Herald-Republic

    The Roses’ Review: Olivia Colman and Benedict Cumberbatch Shine in Dark Comedy Delight

    ‘When Calls the Heart’ Fans All Want the Same Thing After Seeing the Show’s Latest Update – yahoo.com

    When Calls the Heart’ Fans Rally Together in Excitement Over Exciting New Update!

    Quotes of the Week: Peacemaker, Project Runway, Countdown and More – yahoo.com

    This Week’s Most Memorable Quotes from Peacemaker, Project Runway, Countdown, and More!

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    ITSWC 2025: Thursday sessions guide – Traffic Technology Today

    Your Ultimate Guide to Thursday Sessions at ITSWC 2025

    MC Machinery Technology Summit Showcases Manufacturing Innovations – Modern Machine Shop

    MC Machinery Technology Summit Unveils Cutting-Edge Manufacturing Innovations

    US-ROK Technology Cooperation Faces Rising Tensions – The National Interest

    Rising Tensions Put US-South Korea Technology Partnership to the Test

    The Role of AI and Technology in Shaping the Future of Interactive Entertainment – Technology Org

    How AI and Technology Are Transforming the Future of Interactive Entertainment

    Ten upcoming sports stadiums where technology takes to the field – Dezeen

    10 Futuristic Sports Stadiums Revolutionizing the Game with Cutting-Edge Technology

    Figure Technology Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering – Business Wire

    Figure Technology Solutions, Inc. Unveils Exciting Plans for Its Upcoming Initial Public Offering

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Advisory Panel Votes Against Once-Weekly Insulin for T1D

May 26, 2024
in Health
Advisory Panel Votes Against Once-Weekly Insulin for T1D
Share on FacebookShare on Twitter

In a 7 to 4 vote, an advisory panel to the US Food and Drug Administration (FDA) determined that the potential benefits of the investigational once-weekly basal insulin analog icodec (Novo Nordisk) don’t outweigh the increased risk for hypoglycemia in people with type 1 diabetes. 

The May 24 meeting of the Endocrinologic and Metabolic Drugs Advisory Committee was convened specifically to advise the FDA of the benefits versus risks of icodec in people with type 1 diabetes based on the results of ONWARDS-6, one of Novo Nordisk’s randomized clinical trials of icodec. 

Five other ONWARDS trials were conducted in people with type 2 diabetes. The FDA hasn’t publicly raised concerns about efficacy and safety seen in any of those trials. 

In the phase 3a ONWARDS-6, in which 290 patients were randomized to icodec and 292 patients to once-daily degludec (Tresiba), icodec was noninferior in improving A1c at 26 weeks. However, there was a significant increase in serious or severe hypoglycemia with icodec compared with degludec (4.66 vs 1.0 events per 100 patient-years; 14 events in nine patients versus three in three patients), with the greatest incidence in the icodec group on days 2-4 after injection. None of the events resulted in treatment discontinuation or study withdrawal. 

Novo Nordisk representatives presented several possible risk mitigation strategies for icodec, including limiting use to patients wearing a continuous glucose monitor (CGM), restricting use to people with low glycemic variability, avoiding use in those with a history of hypoglycemic unawareness, and/or using alternative dosing strategies such as reducing mealtime bolus insulin doses on days 2-4 after injection. 

Panel members discussed at length whether the potential advantages of once-weekly versus daily basal dosing, such as possible improved adherence and convenience, outweighed the increased risk of hypoglycemia and whether the mitigation strategies would be workable in the real world. Regardless of their vote, most panelists agreed that the company should conduct further trials to gather evidence for the proposed mitigation strategies and determine which patients with type 1 diabetes could benefit most from the drug. 

Need for Contingencies “Makes Me Nervous”

Committee chair Cecilia C. Low Wang, MD, professor of medicine at the University of Colorado Anschutz Medical Campus, voted no to the benefits of icodec outweighing the risks, explaining: “I struggled with the vote because I think adding more treatment options…is super important for my patients with diabetes, especially my patients with type 1 diabetes, because that’s kind of an under-investigated area right now…I’m concerned that approving icodec for use at this point with inadequate data might be a disincentive for further trials, which I think are needed to use it safely in type 1 diabetes.” 

Panel member Matthew T. Drake, MD, PhD, of the Division of Endocrinology at Mayo Clinic College of Medicine, Rochester, Minnesota, also voted no, noting that “when compared to the current gold-standard degludec, which has a good safety profile in my experience, and based on review of the data today, this was an incremental increase [in hypoglycemia].”

Moreover, “I am also concerned about the potential that this would need to be sort of approved with contingencies, specifically the need for CGM. So that makes me nervous. The patients who may be most likely to benefit from this in my clinical practice are unfortunately the ones who tend to be the least likely to actually monitor their blood sugars with some regularity.”

A New Paradigm for Insulin Administration

Rita R. Kalyani, MD, professor of medicine in the Division of Endocrinology, Diabetes, & Metabolism at Johns Hopkins University School of Medicine in Baltimore, Maryland, also cited the need for further studies of patient-reported outcomes, subgroups who would benefit the most, and optimal titration schedules. 

Nonetheless, she voted yes. “As a once-weekly insulin, icodec offers a new paradigm for insulin administration, which may reduce treatment burden and facilitate medication-taking behavior for some individuals with type 1 diabetes. On the other hand, bolus dose adjustment required to prevent hypoglycemia during days 2 to 4, and potentially to prevent hyperglycemia on days 5 to 7, may add to the treatment complexity.”

However, Kalyani said, “Overall given that the primary outcome for A1c efficacy has been demonstrated as noninferior to insulin degludec, risk mitigation strategies to prevent and identify hypoglycemia in a timely manner are available ideally through CGM or alternatively self-monitoring blood glucose, and that effective treatments for hypoglycemia are readily available, guided by the compelling need to offer people with diabetes another treatment option to choose from as part of patient-centered care, my vote is yes.”

Patient representative Paul Tibbits, Jr, a health policy and communications professional in Washington, DC, also voted yes but said the decision was “a significant struggle” and icodec “is only approvable with significant caveats.” 

Tibbits added, “I certainly want to help people with diabetes, but I also don’t want to hurt them. And I think this product has the potential to do both. So, I would put the onus on the FDA to work with the applicant to make sure that if this is approved there are as many guardrails as possible to make sure we don’t harm people with type 1 diabetes.”

Technology, When Possible, Is “First Choice”

Asked to comment, endocrinologist Anne L. Peters, MD, director of the University of Southern California Westside Center for Diabetes, Los Angeles, told Medscape Medical News that automated insulin delivery (AID) systems, which only use short-acting insulin, are her first choice of treatment for patients with type 1 diabetes — and even some with type 2 diabetes — who are able to access and use them “because we’re talking about a system that is infinitely adjustable versus a system that is infinitely not adjustable…It’s night-and-day different.”

However, she also said select patients with type 1 diabetes might benefit from a once-weekly basal insulin, particularly those not using an AID system who don’t reliably take their daily doses. “This would give them a baseline of insulin that could be helpful…There are so many times when I’m in type 1 clinic in [an under-resourced part of Los Angeles] that I wish I had a once-weekly insulin because it would keep people out of the hospital…It certainly isn’t for everybody, but then nothing is.” 

Insulin icodec was approved earlier this year in Canada, Switzerland, and the European Union for people with type 1 or type 2 diabetes.

Advisory panel members are vetted for disclosures and waivers granted for participation if needed, but none were required for this meeting. Peters has reported serving on advisory boards for Abbott Diabetes Care, Becton Dickinson, Boehringer Ingelheim, Eli Lilly, Lexicon Pharmaceuticals, Livongo, Medscape, Merck, Novo Nordisk, Omada Health, Optum Health, sanofi, and Zafgen. She has reported receiving research support from Dexcom, MannKind, and AstraZeneca, and serving as a member of a speakers bureau for Novo Nordisk. 

Miriam E. Tucker is a freelance journalist based in the Washington, DC, area. She is a regular contributor to Medscape, with other work appearing in the Washington Post, NPR’s Shots blog, and Diatribe. She is on X (formerly Twitter) @MiriamETucker. 

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Medscape – https://www.medscape.com/viewarticle/advisory-panel-votes-against-once-weekly-insulin-type-1-2024a10009we

Tags: advisoryhealthPanel
Previous Post

India heatwave news live: Akola hottest city in Maharashtra, Section 144 imposed

Next Post

Semaglutide Significantly Improves Chronic Kidney Disease

Fed Governor Lisa Cook Sues Trump Over Dismissal – The New York Times

Fed Governor Lisa Cook Takes Legal Action Against Trump Over Dismissal

August 28, 2025
Ecological Concerns – The Portugal News

Rising Ecological Concerns Threaten Portugal’s Natural Heritage

August 28, 2025
Scientists warn ocean-based climate fixes lack rules and oversight – Mongabay

Scientists warn ocean-based climate fixes lack rules and oversight – Mongabay

August 28, 2025
Posco student volunteers take science projects abroad – The Korea Herald

Posco Student Volunteers Ignite Curiosity with Science Projects in Communities Abroad

August 28, 2025
Mediterranean diet with lifestyle changes lowers diabetes risk by 31% – News-Medical

Adopting a Mediterranean Diet and Lifestyle Cuts Diabetes Risk by 31%

August 28, 2025
ITSWC 2025: Thursday sessions guide – Traffic Technology Today

Your Ultimate Guide to Thursday Sessions at ITSWC 2025

August 28, 2025
Real Madrid Graduate School Universidad Europea and UNO Launch Dual Degree in Sports Management – University of Nebraska Omaha

Real Madrid Graduate School and UNO Launch Exciting New Dual Degree in Sports Management

August 28, 2025
Hamburg Township baton twirlers capture world championship title in Italy – WXYZ Channel 7

Hamburg Township Baton Twirlers Triumph as World Champions in Italy

August 28, 2025
Diversification helps Minnesota farm navigate ag economy slump – Brownfield Ag News

How Diversification is Powering a Minnesota Farm’s Success During Tough Agricultural Times

August 28, 2025
‘SNL’ Parts Ways With Emil Wakim Amid Rumored Season 51 Cast Shakeup – yahoo.com

SNL Shakes Up Season 51 Cast with Emil Wakim’s Surprising Exit

August 28, 2025

Categories

Archives

August 2025
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (794)
  • Economy (813)
  • Entertainment (21,692)
  • General (16,718)
  • Health (9,854)
  • Lifestyle (827)
  • News (22,149)
  • People (814)
  • Politics (822)
  • Science (16,023)
  • Sports (21,312)
  • Technology (15,794)
  • World (795)

Recent News

Fed Governor Lisa Cook Sues Trump Over Dismissal – The New York Times

Fed Governor Lisa Cook Takes Legal Action Against Trump Over Dismissal

August 28, 2025
Ecological Concerns – The Portugal News

Rising Ecological Concerns Threaten Portugal’s Natural Heritage

August 28, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version